Feasibility and safety of radiofrequency ablation for locally advanced pancreatic cancer.

Pancreatic metastases from renal cell carcinoma: the state of the art. World J Gastroenterol (2011) 1.46

Systematic review of novel ablative methods in locally advanced pancreatic cancer. World J Gastroenterol (2014) 1.33

Endoscopic ultrasound guided radiofrequency ablation, for pancreatic cystic neoplasms and neuroendocrine tumors. World J Gastrointest Surg (2015) 1.11

The problems of radiofrequency ablation as an approach for advanced unresectable ductal pancreatic carcinoma. Cancers (Basel) (2010) 1.09

Radiofrequency ablation for unresectable locally advanced pancreatic cancer: a systematic review. HPB (Oxford) (2013) 0.89

Radiofrequency ablation of pancreatic ductal adenocarcinoma: The past, the present and the future. World J Gastrointest Oncol (2015) 0.88

Commentary on pancreatic carcinoma: the role of radiofrequency ablation in advanced disease. Cancers (Basel) (2010) 0.87

Thermal therapy of pancreatic tumours using endoluminal ultrasound: Parametric and patient-specific modelling. Int J Hyperthermia (2016) 0.86

Pancreaticoduodenectomy for pancreatic cancer: the Verona experience. Surg Today (2011) 0.85

Radiofrequency ablation of locally advanced pancreatic adenocarcinoma: an overview. World J Gastroenterol (2010) 0.85

Results of 100 pancreatic radiofrequency ablations in the context of a multimodal strategy for stage III ductal adenocarcinoma. Langenbecks Arch Surg (2012) 0.84

Local Ablative Strategies for Ductal Pancreatic Cancer (Radiofrequency Ablation, Irreversible Electroporation): A Review. Gastroenterol Res Pract (2016) 0.84

Triple approach strategy for patients with locally advanced pancreatic carcinoma. HPB (Oxford) (2012) 0.83

Optimal combination of radiofrequency ablation with chemoradiotherapy for locally advanced pancreatic cancer. World J Clin Oncol (2012) 0.81

Review of endoscopic radiofrequency in biliopancreatic tumours with emphasis on clinical benefits, controversies and safety. World J Gastroenterol (2016) 0.81

Tumors and new endoscopic ultrasound-guided therapies. World J Gastrointest Endosc (2013) 0.81

Recent advances and limitations of surgical treatment for pancreatic cancer. World J Clin Oncol (2011) 0.80

Irreversible Electroporation. Semin Intervent Radiol (2015) 0.78

Feasibility and safety of electrochemotherapy (ECT) in the pancreas: a pre-clinical investigation. Radiol Oncol (2015) 0.77

Variation of tumoral marker after radiofrequency ablation of pancreatic adenocarcinoma. J Gastrointest Oncol (2016) 0.76

Percutaneous Radiofrequency Ablation of Unresectable Locally Advanced Pancreatic Cancer: Preliminary Results. Technol Cancer Res Treat (2016) 0.76

Surgery for oligometastasis of pancreatic cancer. Chin J Cancer Res (2015) 0.76

Perfusion CT estimates photosensitizer uptake and biodistribution in a rabbit orthotopic pancreatic cancer model: a pilot study. Acad Radiol (2015) 0.76

Percutaneous ablation of pancreatic cancer. World J Gastroenterol (2016) 0.75

Endoluminal ultrasound applicators for MR-guided thermal ablation of pancreatic tumors: Preliminary design and evaluation in a porcine pancreas model. Med Phys (2016) 0.75

Does ablation technique utilized in the management of unresectable locally advanced pancreatic adenocarcinoma? Cancers (Basel) (2010) 0.75

Electrochemotherapy in pancreatic adenocarcinoma treatment: pre-clinical and clinical studies. Radiol Oncol (2016) 0.75

Intratumoral radiofrequency hyperthermia-enhanced direct chemotherapy of pancreatic cancer. Oncotarget (2016) 0.75

Temperature feedback-controlled photothermal treatment with diffusing applicator: theoretical and experimental evaluations. Biomed Opt Express (2016) 0.75

Thermal ablation of pancreatic cyst with a prototype endoscopic ultrasound capable radiofrequency needle device: A pilot feasibility study. Endosc Ultrasound (2017) 0.75

Endoscopic ultrasound-guided radiofrequency ablation in gastroenterology: New horizons in search. World J Gastroenterol (2017) 0.75

Early radiological assessment of locally advanced pancreatic cancer treated with electrochemotherapy. World J Gastroenterol (2017) 0.75

Adjuvant chemoradiotherapy and chemotherapy in resectable pancreatic cancer: a randomised controlled trial. Lancet (2001) 5.75

Mucinous cystic tumors of the pancreas: clinicopathological features, prognosis, and relationship to other mucinous cystic tumors. Am J Surg Pathol (1999) 3.36

Influence of resection margins on survival for patients with pancreatic cancer treated by adjuvant chemoradiation and/or chemotherapy in the ESPAC-1 randomized controlled trial. Ann Surg (2001) 2.94

Genetic profile of 22 pancreatic carcinoma cell lines. Analysis of K-ras, p53, p16 and DPC4/Smad4. Virchows Arch (2001) 2.73

Efficacy of octreotide in the prevention of complications of elective pancreatic surgery. Italian Study Group. Br J Surg (1994) 2.51

Meta-analysis of randomised adjuvant therapy trials for pancreatic cancer. Br J Cancer (2005) 2.32

Management of complications after pancreaticoduodenectomy in a high volume centre: results on 150 consecutive patients. Dig Surg (2001) 2.08

Diagnosis, objective assessment of severity, and management of acute pancreatitis. Santorini consensus conference. Int J Pancreatol (1999) 2.03

Development of a disease specific quality of life (QoL) questionnaire module to supplement the EORTC core cancer QoL questionnaire, the QLQ-C30 in patients with pancreatic cancer. EORTC Study Group on Quality of Life. Eur J Cancer (1999) 1.99

Guidelines for the management of acute pancreatitis. J Gastroenterol Hepatol (2002) 1.92

A randomized multicenter clinical trial of antibiotic prophylaxis of septic complications in acute necrotizing pancreatitis with imipenem. Surg Gynecol Obstet (1993) 1.91

Enucleation of pancreatic neoplasms. Br J Surg (2007) 1.88

Antibiotic therapy for prophylaxis against infection of pancreatic necrosis in acute pancreatitis. Cochrane Database Syst Rev (2003) 1.74

Adjuvant 5-fluorouracil and folinic acid vs observation for pancreatic cancer: composite data from the ESPAC-1 and -3(v1) trials. Br J Cancer (2009) 1.69

Gene expression profiles of pancreatic cancer and stromal desmoplasia. Oncogene (2001) 1.68

Alcohol and smoking as risk factors in chronic pancreatitis and pancreatic cancer. Dig Dis Sci (1999) 1.59

Isolation measures for prevention of infection with respiratory pathogens in cystic fibrosis: a systematic review. J Hosp Infect (2006) 1.57

Clinicopathological features and treatment of intraductal papillary mucinous tumour of the pancreas. Br J Surg (2001) 1.53

Infected pancreatic necrosis and peripancreatic fluid collections: serendipitous response to antibiotics and medical therapy in three patients. Pancreas (1996) 1.47

Prevalence and risk factors of extrapancreatic malignancies in a large cohort of patients with intraductal papillary mucinous neoplasm (IPMN) of the pancreas. Ann Oncol (2013) 1.47

Regression of an established tumor genetically modified to release granulocyte colony-stimulating factor requires granulocyte-T cell cooperation and T cell-produced interferon gamma. J Exp Med (1993) 1.43

Alcohol intake, cigarette smoking, and body mass index in patients with alcohol-associated pancreatitis. J Clin Gastroenterol (2000) 1.42

Adjuvant therapy in pancreatic cancer: historical and current perspectives. Ann Oncol (2003) 1.42

Changes in pancreatic resection for chronic pancreatitis over 28 years in a single institution. Br J Surg (2000) 1.40

Pancreatic tumours: molecular pathways implicated in ductal cancer are involved in ampullary but not in exocrine nonductal or endocrine tumorigenesis. Br J Cancer (2001) 1.36

Pancreatic insufficiency after different resections for benign tumours. Br J Surg (2008) 1.31

Incidence of cancer in the course of chronic pancreatitis. Am J Gastroenterol (1999) 1.24

Controlled clinical trial of pefloxacin versus imipenem in severe acute pancreatitis. Gastroenterology (1998) 1.23

Prognostic factors at diagnosis and value of WHO classification in a mono-institutional series of 180 non-functioning pancreatic endocrine tumours. Ann Oncol (2008) 1.23

Prospective randomized double-blind trial of neurolytic coeliac plexus block in patients with pancreatic cancer. Br J Surg (1998) 1.22

Long-term follow-up of patients with chronic pancreatitis in Italy. Scand J Gastroenterol (1998) 1.15

Combined modality treatment for patients with locally advanced pancreatic adenocarcinoma. Br J Surg (2012) 1.10

When off-label is a good practice: the example of paracetamol and salbutamol. Arch Dis Child (2008) 1.08

Prospective multicentre survey on acute pancreatitis in Italy (ProInf-AISP): results on 1005 patients. Dig Liver Dis (2004) 1.06

Alcohol, smoking and papillomavirus infection as risk factors for esophageal squamous-cell papilloma and esophageal squamous-cell carcinoma in Italy. Int J Cancer (2000) 1.06

"Paraduodenal" pancreatitis: results of surgery on 58 consecutives patients from a single institution. World J Surg (2009) 1.05

Conservative treatment of external pancreatic fistulas with parenteral nutrition alone or in combination with continuous intravenous infusion of somatostatin, glucagon or calcitonin. Surg Gynecol Obstet (1986) 1.04

Respiratory training with a specific device in cystic fibrosis: a prospective study. J Cyst Fibros (2008) 1.02

Primary tumour resection in metastatic nonfunctioning pancreatic endocrine carcinomas. Dig Liver Dis (2008) 1.02

Antibiotic therapy for prophylaxis against infection of pancreatic necrosis in acute pancreatitis. Cochrane Database Syst Rev (2006) 1.02

Cigarette smoking: an independent risk factor in alcoholic pancreatitis. Pancreas (1996) 0.99

Treatment and prevention of osteoporosis in juvenile chronic arthritis with disodium clodronate. Clin Exp Rheumatol (1991) 0.99

Branch duct IPMTs: value of cross-sectional imaging in the assessment of biological behavior and follow-up. Abdom Imaging (2005) 0.98

Stump appendicitis seven years after appendectomy. APSP J Case Rep (2013) 0.98

[Polyorchidism: 2 case reports]. Arch Ital Urol Androl (1997) 0.98

Acoustic radiation force impulse (ARFI) ultrasound imaging of pancreatic cystic lesions. Eur J Radiol (2010) 0.98

Effectiveness of gabexate mesilate in acute pancreatitis. A metaanalysis. Dig Dis Sci (1995) 0.95

Outcome of open necrosectomy in acute pancreatitis. Pancreatology (2003) 0.94

Outcome and quality of life in chronic pancreatitis. JOP (2001) 0.94

Review of the clinical, histological, and molecular aspects of pancreatic endocrine neoplasms. J Surg Oncol (2002) 0.93

Risk of death from acute pancreatitis. Role of early, simple "routine" data. Int J Pancreatol (1996) 0.92

Thoracic complications of pancreatitis. Pancreas (1989) 0.91

Endovascular treatment of arterial bleeding in patients with pancreatitis. Pancreatology (2007) 0.91

Coeliac disease, folic acid deficiency and epilepsy with cerebral calcifications. Acta Paediatr Scand (1991) 0.91

Intrahepatic peripheral cholangiocarcinoma (IPCC): comparison between perfusion ultrasound and CT imaging. Radiol Med (2008) 0.90

ESPAC-1 trial progress report: the European randomized adjuvant study comparing radiochemotherapy, 6 months chemotherapy and combination therapy versus observation in pancreatic cancer. Digestion (1997) 0.90

Practical guidelines for acute pancreatitis. Pancreatology (2010) 0.90

Preemptive ketamine during general anesthesia for postoperative analgesia in patients undergoing laparoscopic cholecystectomy. Minerva Anestesiol (2004) 0.90

Prophylaxis for septic complications in acute necrotizing pancreatitis. J Hepatobiliary Pancreat Surg (2001) 0.89

Necrosectomy by lavage in the surgical treatment of severe necrotizing pancreatitis. Results in 263 patients. Acta Chir Scand (1991) 0.89

Role of chemoembolization in synchronous liver metastases from pancreatic endocrine tumours. Dig Surg (1999) 0.88

Prospective comparison of C-reactive protein level, Ranson score and contrast-enhanced computed tomography in the prediction of septic complications of acute pancreatitis. Br J Surg (1993) 0.88

Serum creatinine and chest radiographs in the early assessment of acute pancreatitis. Am J Surg (1999) 0.88

Hemolytic anemia secondary to interferon treatment for chronic B hepatitis. J Clin Gastroenterol (1991) 0.86

Lactobacillus plantarum reduces infection of pancreatic necrosis in experimental acute pancreatitis. Dig Surg (2001) 0.86

Pain in cognitively impaired children: a focus for general pediatricians. Eur J Pediatr (2012) 0.86

Evidence-based assessment of severity and management of acute pancreatitis. Br J Surg (2000) 0.86

Long-term outcome of acute pancreatitis: a prospective study with 118 patients. Digestion (1993) 0.85

Retroperitoneal and peritoneal drainage and lavage in the treatment of severe necrotizing pancreatitis. Surg Gynecol Obstet (1990) 0.85

Cystic "feminine" pancreatic neoplasms in men. Do any clinical alterations correlate with these uncommon entities? Int J Surg (2012) 0.85

Cytotoxic T lymphocytes recognize tumor antigens of a murine colonic carcinoma by using different T-cell receptors. Int J Cancer (1994) 0.85

Ofloxacin penetration into bile and pancreatic juice. J Antimicrob Chemother (1989) 0.85

Surgical treatment of pancreatic metastases from renal cell carcinomas. Dig Surg (1998) 0.85

Carcinoma of pancreatic body and tail: are there improvements in diagnosis and treatment modalities over the past decade? Dig Liver Dis (2003) 0.84

Inefficacy of etanercept in a child with hyper-IgD syndrome and periodic fever. Clin Exp Rheumatol (2005) 0.84

Pancreatic cystic manifestations in von Hippel-Lindau disease. Int J Pancreatol (1997) 0.84

Meta-analysis of pancreaticojejunostomy versus pancreaticogastrostomy reconstruction after pancreaticoduodenectomy: authors' comment (Br J Surg 2006; 93: 929-936). Br J Surg (2006) 0.83

Early detection of pancreatic cancer following the diagnosis of chronic pancreatitis. Digestion (2000) 0.83

Ciprofloxacin penetration in pancreatic juice. Chemotherapy (1987) 0.83

Molecular pathogenesis of sporadic duodenal cancer. Br J Cancer (1998) 0.83

Autoimmune pancreatitis: possibilities of CT characterization. Pancreatology (2001) 0.83

Two novel POLG mutations causing hepatic mitochondrial DNA depletion with recurrent hypoketotic hypoglycaemia and fatal liver dysfunction. Dig Liver Dis (2009) 0.82

Infection prevention in necrotizing pancreatitis: an old challenge with new perspectives. J Hosp Infect (2001) 0.82

ESPEN Guidelines on Parenteral Nutrition: pancreas. Clin Nutr (2009) 0.82